Search Results - "O'ROURKE, T. J"

Phase II trial of paclitaxel by 24-hour continuous infusion for relapsed non-Hodgkin's lymphomas: Southwest Oncology Group trial 9246 by Press, O W, LeBlanc, M, O'Rourke, T J, Gagnet, S, Chapman, R A, Balcerzak, S P, Fisher, R I

“…The Southwest Oncology Group (SWOG) recently conducted a multiinstitutional phase II trial to determine the complete response (CR) and partial response (PR)…”
Get more information

Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days by O'Rourke, T J, Brown, T D, Havlin, K, Kuhn, J G, Craig, J B, Burris, H A, Satterlee, W G, Tarassoff, P G, Von Hoff, D D

Get more information

Could lean and green be the driver to integrate business improvement throughout the organisation? by Chaplin, Lara, O’Rourke, Simon T.J

“…Purpose It seems to be the consensus (Zhang et al., 2012; George et al., 2003; Arumugam et al., 2013) that Lean Six Sigma (LSS) has become a beneficial…”
Get full text

Could “Lean Lite” be the cost effective solution to applying lean manufacturing in developing economies? by Chaplin, Lara, Heap, John, O'Rourke, Simon T.J

“…Purpose – The purpose of this paper is to suggest a solution to the problem of implementing a full “Lean” methodology for small-/medium-sized enterprises…”
Get full text

Phase I clinical trial of ormaplatin (tetraplatin, NSC 363812) by O'Rourke, T J, Weiss, G R, New, P, Burris, 3rd, H A, Rodriguez, G, Eckhardt, J, Hardy, J, Kuhn, J G, Fields, S, Clark, G M

“…Ormaplatin is a platinum analog that was developed because of an altered toxicity profile and non-cross resistance to cisplatin in both in vitro and in vivo…”
Get more information

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies by BURRIS, H. A, RAYMOND, E, AWADA, A, KUHN, J. G, O'ROURKE, T. J, BRENTZEL, J, LYNCH, W, KING, S.-Y. P, BROWN, T. D, VON HOFF, D. D

“…Brequinar (DUP 785; NSC 368390) is a quinoline carboxylic acid derivative that inhibits pyrimidine synthesis at the level of dihydro-orotate dehydrogenase and…”
Get full text

Phase I clinical and pharmacokinetic trial of brequinar sodium (DUP 785; NSC 368390) by ARTEAGA, C. L, BROWN, T. D, KUHN, J. G, SHEN, H.-S. L, O'ROURKE, T. J, BEOUGHER, K, BRENTZEL, H. J, VON HOFF, D. D, WEISS, G. R

“…Brequinar sodium is a 4-quinolinecarboxylic acid analogue that inhibits dihydroorotate dehydrogenase and subsequent de novo pyrimidine biosynthesis. It has…”
Get full text

Hemophagocytic syndrome: a cause of pancytopenia in human ehrlichiosis by Abbott, K C, Vukelja, S J, Smith, C E, McAllister, C K, Konkol, K A, O'Rourke, T J, Holland, C J, Ristic, M

“…A 67-year-old white man with human ehrlichiosis infection complicated by pancytopenia, hemophagocytic syndrome, disseminated intravascular coagulopathy and…”
Get more information

Expectations and experiences of patients with cancer participating in phase I clinical trials by Yoder, L H, O'Rourke, T J, Etnyre, A, Spears, D T, Brown, T D

“…To describe the expectations and experiences of patients entering phase I clinical trials. Descriptive, exploratory, prospective. A large military medical…”
Get more information

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule by Brown, T D, O'Rourke, T J, Kuhn, J G, Craig, J B, Havlin, K, Burris, 3rd, H A, Cagnola, J, Hamilton, J M, Grindey, G B, Satterlee, W G

“…Sulofenur (LY186641), a diarylsulfonylurea, was evaluated clinically utilizing either a daily x 21 schedule or a daily x 5 (with 2 days off) for 3 weeks…”
Get more information

Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial by Parrino, Janie, Popmihajlov, Zoran, Annunziato, Paula W, Fein, L, Singh, M, Morrissey, O, Kuehr, T, Duck, L, De Prijck, B, Serrano, SV, Camargo, JFC, Radinov, A, Minchev, V, Grimard, D, Weiss, K, Diaz-Mitoma, FJ, Torres Ulloa, R, Fardella, P, Gonzalez, P, Gonzalez, ME, Rojas, CA, Paulson, G, Ontaneda, M, Laine, F, Laurichesse, H, Duval, X, Cornely, OA, Zaiss, M, Verbeek, M, Georgoulias, V, Terpos, E, Umanzor, J, Bejarano, S, Gentile, G, Rambaldi, A, Marei, L, Abbadi, A, Kattan, J, Blacklock, H, Tiangco, BJ, Cabanillas, F, Ciuleanu, TE, Cainap, CI, Dvorkin, MV, Litvinov, IV, Goh, YT, Matejkova, M, Reckova, M, Yoon, SS, Duran Martinez, I, Chen, C-Y, Sriuranpong, V, Akan, H, Mullan, SR, Sivarajan, K, Marquez, F, Mullane, MR, Mazurczak, MA, Zenk, D, Robinson, MO, Naqvi, T, Ahmed, M, Badarinath, S, Kendall, SD, Chedid, S, Rafiyath, S, Buechler-Price, J, Sreenivasappa, S, Geller, R, Nieva, J, Wong, BMY, Ibrahim, EN, Oliff, IA, Guter, KA, Rao, SB, Columbie, A, Nualart, MT, Campos, LT, Sharma, S, Ortiz, T, Markowitz, AB, Koo, VS, Murray, C, Gurtler, JS, Ascensao, JL, Santander, JL, Garg, RJ, Lowry, P, Baker, J, Roeland, E, Payne, JE, Betts, RF, Sharp, SA, Congdon, J, Wos, EJ, Hutchins, M, Chowhan, NM, O'Rourke, TJ, Winkler, CF, Duic, JP

“…Patients who are immunocompromised because of malignancy have an increased risk of herpes zoster and herpes zoster-related complications. We aimed to…”
Get full text

New anticancer agents by Brown, T D, Burris, H A, Havlin, K A, O'Rourke, T J, Rodriguez, G I, Wall, J G, Weiss, G R

Get more information

Acute myeloid leukemia evolving from essential thrombocythemia in two patients treated with hydroxyurea by Furgerson, James L., Vukelja, Svetislava J., Baker, W. Jeffrey, O'Rourke, Timothy J.

“…Essential thrombocythemia (ET) is an uncommon myeloproliferative disorder, which is thought to develop from a multipotent stem cell. Like other…”
Get full text

The relation of the physical character of the diet to the health of the periodontal tissues; a critical review of the literature by O'ROURKE, J T

Get more information

Significance of tests for biting strength by O'ROURKE, J T

Get more information

Dental care for children in relation to geriatrics by O'ROURKE, J T

Get more information

Vegetative Response following Pinyon-Juniper Control in Arizona by J. T. O'Rourke, P. R. Ogden

“…Mean percentage calcium carbonate levels of near 13% in the surface foot of soil and low pinyon-juniper crown cover (13% and 26%) were associated with no…”
Get full text

Lean Six Sigma and marketing: a missed opportunity by Chaplin, Lara, T.J. O’Rourke, Simon

“…Purpose – The purpose of this paper is to assess the current use being made of the sustainability message within business improvement activity and project…”
Get full text

General discussion of the teaching of oral diagnosis by O'ROURKE, J T

Get more information

Analysis of a survey of dental hygienists in the United States by O'ROURKE, J T

Get more information